Assertio Holdings Sees Rolvedon Sales Surge in Q2 2024
Rolvedon sales drive growth at Assertio Holdings in Q2 2024. CEO highlights a strong balance sheet amid slight sales decline.
- Latest
- Trending
Rolvedon sales drive growth at Assertio Holdings in Q2 2024. CEO highlights a strong balance sheet amid slight sales decline.
AI firms challenge California bill mandating safety tests to prevent catastrophic harm, fearing impact on innovation.
Ethereum-based CryptoPunks hit $663K in NFT sales, ranking third in the industry, highlighting a diverse and competitive market.
Rayonier Advanced Materials Inc. boosts EBITDA and cash flow forecasts, driven by robust segments and strategic initiatives.
Viasat raises 2025 revenue forecast due to increased demand in aviation and defense sectors, expecting slight growth.
RBC analysts believe that reducing Tesla's FSD subscription price could drive stock performance, despite recent challenges.
Bumble's third-quarter revenue forecast misses Wall Street estimates, leading to a significant drop in shares. Learn more inside.
Treace Medical Concepts reported a 6% rise in Q2 revenue to $44.5M, driven by new products and a growing surgeon ...
BTB REIT reports mixed Q2 results with record occupancy but declining FFO per unit. Financial strategies and market shifts impact ...
Supernus Pharmaceuticals sees a 24% YoY revenue increase in Q2 2024, driven by key drugs Qelbree and GOCOVRI.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.